Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesCash from Financing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet IncomeShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

SeaStar Medical Holding (ICU) Change in Accured Expenses (2023 - 2025)

SeaStar Medical Holding (ICU) has disclosed Change in Accured Expenses for 3 consecutive years, with -$1.1 million as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Change in Accured Expenses fell 569.55% year-over-year to -$1.1 million, compared with a TTM value of -$2.2 million through Sep 2025, down 333.15%, and an annual FY2024 reading of -$100000.0, changed N/A over the prior year.
  • Change in Accured Expenses was -$1.1 million for Q3 2025 at SeaStar Medical Holding, down from -$67000.0 in the prior quarter.
  • Across five years, Change in Accured Expenses topped out at $786000.0 in Q1 2023 and bottomed at -$1.1 million in Q3 2025.
  • Average Change in Accured Expenses over 3 years is -$137888.9, with a median of $21000.0 recorded in 2024.
  • Peak annual rise in Change in Accured Expenses hit 219.05% in 2025, while the deepest fall reached 569.55% in 2025.
  • Year by year, Change in Accured Expenses stood at -$786000.0 in 2023, then plummeted by 31.3% to -$1.0 million in 2024, then fell by 10.56% to -$1.1 million in 2025.
  • Business Quant data shows Change in Accured Expenses for ICU at -$1.1 million in Q3 2025, -$67000.0 in Q2 2025, and $67000.0 in Q1 2025.